Skip to main content

Table 1 Base line profile of patients

From: Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients

 

HbA1C = < 7.0 (Gp.MF)

HbA1C 7.0 < (Gp.MP)

= < 70y.o.

Insulin (-)

Insulin (+)

P

Insulin (-)

Insulin (+)

P

 

Mean(SD)

Mean(SD)

 

Mean(SD)

Mean(SD)

 

Duration of Diabetes (yrs)

6.67 (7.50)

12.18 (9.31)

0.012*

9.53(8.05)

12.48 (8.15)

0.011*

   FBS (mg/dl)

145.2 (44.4)

158.2 (55)

0.022*

183.7(63.4)

173.7(71)

0.134

   SBP (mmHg)

134.4 (15.5)

133.4 (17.6)

0.409

133.4(17.7)

132.7 (18.3)

0.893

   DBP (mmHg)

77 (12.3)

73.2 (14.8)

0.011*

76 (10.9)

73.4(11)

0.04*

   TG (mg/dl)

148.3(119.9)

135.5 (65.3)

0.844

154.1(111.6)

141.9 (184)

0.03*

   HDL-C(mg/dl)

55(14.2)

57.2 (15.1)

0.062

52.8(13.4)

59.7(21.5)

0.001**

   LDL-C(mg/dl)

116.3(31.9)

110.5 (27.9)

0.034*

123.4(35.9)

120.2(33.3)

0.52

 

%

%

P

%

%

P

Gender (Male/total)

61.8

49.6

0.011*

53.3

47.5

0.116

Anti-hyperlipidemic drugs

53.9

49.3

0.131

52.7

58.6

0.477

statin

41.4

39.0

0.122

48.5

45.7

0.444

Oral diabetic drugs

44.4

10

< 0.001**

82.0

6.7

< 0.001**

sulfonylurea

43.0

9.0

< 0.001**

79.4

8.6

< 0.001**

Anti-hypertensive drugs

66.1

47.9

0.042*

54.8

51.0

0.921

70 +y.o.

HbA1C = < 7.0 (Gp.OF)

HbA1C 7.0 < (Gp.OP)

 

Insulin (-)

Insulin (+)

P

Insulin (-)

Insulin (+)

P

 

Mean(SD)

Mean(SD)

 

Mean(SD)

Mean(SD)

 

Duration of Diabetes (yrs)

10.83 (8.75)

12.2 (9.67)

0.12

10.67 (9.17)

11.0 (9.50)

0.43

   FBS (mg/dl)

146.2 (47.1)

159.1 (59)

0.052

174.5 (70.5)

181.7 (75.5)

0.224

   SBP (mmHg)

136.2 (16.4)

135.7 (17)

0.896

136.4 (15.9)

136.2 (17)

0.822

   DBP (mmHg)

71.7 (11.2)

70.4 (11.6)

0.256

73.1 (11.3)

73.1 (11.1)

0.832

   TG (mg/dl)

127.5 (73.4)

124.3 (75.3)

0.168

130.8 (75)

124.6 (69.3)

0.53

   HDL-C (mg/dl)

55.1 (16)

55 (17.3)

0.953

54.7 (16.1)

54.7 (16.5)

0.888

   LDL-C (mg/dl)

114.1 (29)

112.3 (30.3)

0.704

118.2 (30.7)

117.8 (33.6)

0.541

 

%

%

P

%

%

P

Gender (Male/total)

54

45.9

0.061

53.2

37.9

0.035*

Anti-hyperlipidemic drugs

50.2

46.0

0.140

46.7

50

0.307

statin

43.9

40.2

0.003**

43.3

42.5

0.167

Oral diabetic drugs

62.6

18.5

< 0.001**

84.6

19.1

< 0.001**

sulfonylurea

60.1

12.6

< 0.001**

79.4

8.0

< 0.001**

Anti-hypertensive drugs

68.2

59.9

0.904

60.9

54.6

0.370

  1. Characteristics of the patients in each of the four groups, including insulin use. These groups were stratified by glycemic control and age.
  2. *p < 0.05, **p < 0.01.